HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henrik Clausen Selected Research

Disaccharides

10/2009Glycan bioengineering in immunogen design for tumor T antigen immunotargeting.
2/2006The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
5/2005Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henrik Clausen Research Topics

Disease

52Neoplasms (Cancer)
07/2023 - 06/2003
13Carcinoma (Carcinomatosis)
10/2020 - 06/2003
11Breast Neoplasms (Breast Cancer)
01/2015 - 12/2002
9Adenocarcinoma
11/2016 - 03/2008
6Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 03/2008
6Neoplasm Metastasis (Metastasis)
01/2021 - 02/2010
5Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 05/2014
4Infections
07/2023 - 09/2002
3Carcinogenesis
10/2021 - 10/2004
3Calcinosis
01/2020 - 07/2006
3Hyperphosphatemia
01/2020 - 11/2011
3Colorectal Neoplasms (Colorectal Cancer)
05/2016 - 04/2011
2Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2023 - 01/2019
2Thrombocytopenia (Thrombopenia)
12/2021 - 08/2009
2Congenital Disorders of Glycosylation
01/2018 - 02/2015
2Stomach Neoplasms (Stomach Cancer)
06/2015 - 03/2013
2IGA Glomerulonephritis (IGA Nephropathy)
11/2014 - 03/2013
2Multiple Myeloma
05/2014 - 11/2006
2Metaplasia
04/2013 - 01/2011
2Disease Progression
04/2013 - 10/2010
2Hyperostosis
12/2012 - 11/2011
2Prostatic Neoplasms (Prostate Cancer)
02/2010 - 12/2007
1Nervous System Diseases (Neurological Disorders)
03/2024
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022
1Influenza in Birds (Avian Flu)
01/2022
1Arthritis (Polyarthritis)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Leukemia
01/2022
1Type 2 Diabetes Mellitus (MODY)
10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021

Drug/Important Bio-Agent (IBA)

24Polysaccharides (Glycans)IBA
01/2023 - 10/2004
20MucinsIBA
01/2022 - 06/2003
17Glycoproteins (Glycoprotein)IBA
01/2023 - 06/2005
17AntigensIBA
01/2020 - 06/2003
14Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2002
13EpitopesIBA
01/2022 - 06/2003
12Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2010
11AntibodiesIBA
01/2023 - 10/2003
11GlycopeptidesIBA
01/2020 - 02/2006
8Mucin-1 (CA 15-3 Antigen)IBA
01/2016 - 10/2004
7Peptides (Polypeptides)IBA
01/2020 - 06/2003
7GlycosyltransferasesIBA
01/2018 - 06/2003
7VaccinesIBA
11/2015 - 10/2003
6CarbohydratesIBA
01/2020 - 06/2003
6Monoclonal AntibodiesIBA
05/2014 - 05/2005
5EnzymesIBA
01/2023 - 01/2011
5LectinsIBA
10/2020 - 10/2009
5Chimeric Antigen ReceptorsIBA
01/2020 - 01/2016
5AutoantibodiesIBA
05/2014 - 02/2010
5Polypeptide N-acetylgalactosaminyltransferaseIBA
06/2012 - 07/2006
4Galactose (Galactopyranose)FDA LinkGeneric
10/2020 - 09/2007
4Tumor Viral Antigens (Large T Antigen)IBA
01/2019 - 10/2009
4keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
12/2007 - 10/2003
3SialyltransferasesIBA
01/2022 - 02/2006
3Sialyl Lewis X AntigenIBA
01/2021 - 07/2012
3Protein Isoforms (Isoforms)IBA
01/2021 - 03/2012
3C-Type Lectins (C-Type Lectin)IBA
10/2020 - 09/2007
3AcetylgalactosamineIBA
01/2020 - 04/2012
3Tn antigenIBA
01/2020 - 01/2007
3Surface Antigens (Surface Antigen)IBA
01/2020 - 10/2003
3Tumor Biomarkers (Tumor Markers)IBA
11/2015 - 02/2015
3DisaccharidesIBA
10/2009 - 05/2005
3saponin QA-21V1 (QS21)IBA
12/2007 - 05/2005
2Indicators and Reagents (Reagents)IBA
01/2022 - 08/2010
2GemcitabineFDA Link
10/2021 - 01/2021
2SugarsIBA
10/2020 - 01/2020
2Threonine (L-Threonine)FDA Link
01/2020 - 05/2005
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2020 - 08/2013
2Cadherins (E-Cadherin)IBA
01/2020 - 12/2013
2Serine (L-Serine)FDA Link
01/2020 - 05/2005
2AutoantigensIBA
01/2016 - 03/2008
2Immunoglobulin A (IgA)IBA
11/2014 - 03/2013
2Transcription Factors (Transcription Factor)IBA
12/2013 - 05/2012
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
04/2013 - 07/2012
2Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
04/2013 - 07/2012
2sialosyl-Tn antigenIBA
01/2011 - 10/2004
2MonosaccharidesIBA
12/2010 - 05/2005
2GlycoconjugatesIBA
10/2009 - 10/2005
2TransferasesIBA
01/2007 - 06/2003
2SaponinsIBA
05/2005 - 10/2003
1Proteoglycans (Proteoglycan)IBA
03/2024
1Carisoprodol (Soma)FDA LinkGeneric
01/2023
1Sialic AcidsIBA
01/2023
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2023
1GlycosphingolipidsIBA
01/2023
1sialic acid receptorIBA
01/2022
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1monomethyl auristatin EIBA
01/2022
1podocalyxinIBA
01/2022
1Platelet Factor 4IBA
12/2021
1Heparin (Liquaemin)FDA LinkGeneric
12/2021
1AnticoagulantsIBA
12/2021
1Insulin (Novolin)FDA Link
10/2021
1NucleosidesIBA
10/2021
1SelectinsIBA
01/2021

Therapy/Procedure

7Therapeutics
07/2023 - 11/2006
4Immunotherapy
04/2013 - 02/2006
3Ligation
06/2015 - 07/2012
2Enzyme Replacement Therapy
01/2023 - 01/2019